NR3C1 and invasive breast carcinoma: The literature reports on nuclear GR expression are heterogeneous, ranging from a consistent lack of GR staining in almost all invasive breast carcinomas (except metaplastic tumours) to varying positivity rates between 44% and 83% [9,10,12,24].